Follow
Kirti Gondkar
Kirti Gondkar
Zydus Life Sciences Ltd
Verified email at ibioinformatics.org
Title
Cited by
Cited by
Year
E74 like ETS transcription factor 3 (ELF3) is a negative regulator of epithelial-mesenchymal transition in bladder carcinoma
K Gondkar, K Patel, S Krishnappa, A Patil, B Nair, GM Sundaram, TT Zea, ...
Cancer Biomarkers 25 (2), 223-232, 2019
262019
Dickkopf Homolog 3 (DKK3) Acts as a Potential Tumor Suppressor in Gallbladder Cancer
K Gondkar, K Patel, GV Patil Okaly, B Nair, A Pandey, H Gowda, P Kumar
Frontiers in Oncology 9, 1121, 2019
202019
Phosphoproteomic profiling identifies aberrant activation of integrin signaling in aggressive non-type bladder carcinoma
B Deb, VN Puttamallesh, K Gondkar, JP Thiery, H Gowda, P Kumar
Journal of clinical medicine 8 (5), 703, 2019
182019
Quantitative Proteomics of Urinary Bladder Cancer Cell Lines Identify UAP1 as a Potential Therapeutic Target
* Vinuth N. Puttamallesh 1,2, Barnali Deb 1,3, Kirti Gondkar 1,2, Ankit Jain ...
Genes 11 (7), 763, 2020
152020
Integrated proteomic and phosphoproteomics analysis of DKK3 signaling reveals activated kinase in the most aggressive gallbladder cancer
K Gondkar, G Sathe, N Joshi, B Nair, A Pandey, P Kumar
Cells 10 (3), 511, 2021
102021
Targeting Gene Fusion Event s in Bladder Carcinoma
J Sharma, K Gondkar, B Deb, P Kumar
J Mol Genet Med 12 (361), 1747-0862.1000361, 2018
22018
Galectin-1 promotes the invasion of bladder cancer urothelia through their matrix milieu
A Balakrishnan, D Pally, K Gondkar, S Naito, D Sidransky, A Chatterjee, ...
bioRxiv, 441642, 2018
12018
Integrative Omics: The Roadmap for Gallbladder Biomarkers Identification
K Gondkar, JR Parvathi, P Kumar
Gallbladder Cancer: Current Treatment Options, 317-330, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–8